{"log_id": 5283725921682402031, "direction": 0, "words_result_num": 33, "words_result": [{"probability": {"variance": 0.000122, "average": 0.986061, "min": 0.975037}, "location": {"width": 46, "top": 247, "height": 26, "left": 239}, "words": "背痛"}, {"probability": {"variance": 0, "average": 0.999714, "min": 0.999387}, "location": {"width": 108, "top": 289, "height": 28, "left": 283}, "words": "心血管系统"}, {"probability": {"variance": 0.000353, "average": 0.993714, "min": 0.893515}, "location": {"width": 681, "top": 329, "height": 34, "left": 282}, "words": "在输注的头3个小时内,低血压的发生率在所有患者中占12%,在所有疗程"}, {"probability": {"variance": 0.00019, "average": 0.995531, "min": 0.9158}, "location": {"width": 722, "top": 371, "height": 33, "left": 240}, "words": "中占3%。在输注的头3个小时,心动过缓的发生率在所有患者中占3%,在所有"}, {"probability": {"variance": 0.01147, "average": 0.971281, "min": 0.48429}, "location": {"width": 722, "top": 412, "height": 33, "left": 239}, "words": "疗程中占1%。在卵巢癌I1期临床研究中,低血压和心动过缓均不受剂量和输注"}, {"probability": {"variance": 9.5e-05, "average": 0.99736, "min": 0.94112}, "location": {"width": 725, "top": 453, "height": 33, "left": 237}, "words": "时间的影响。这些生命体征的改变通常没有症状,也不需要特殊的治疗或者中断"}, {"probability": {"variance": 0.000292, "average": 0.995639, "min": 0.91072}, "location": {"width": 544, "top": 493, "height": 32, "left": 238}, "words": "治疗。低血压和心动过缓的发生不受先前蒽环类治疗的影响"}, {"probability": {"variance": 7.5e-05, "average": 0.997471, "min": 0.949143}, "location": {"width": 679, "top": 534, "height": 35, "left": 280}, "words": "大约1%患者的显著的心血管事件可能与紫杉醇单药治疗相关。这些心血管"}, {"probability": {"variance": 0.000299, "average": 0.993945, "min": 0.896918}, "location": {"width": 723, "top": 575, "height": 36, "left": 237}, "words": "事件包括晕厥、心律失常、高血压、静脉血栓。在紫杉醇175mg/m24小时输注"}, {"probability": {"variance": 0.003013, "average": 0.985255, "min": 0.675784}, "location": {"width": 725, "top": 616, "height": 36, "left": 234}, "words": "的患者中,有1例发生晕厥并进展为低血压而死亡。心律失常包括无症状的室性"}, {"probability": {"variance": 0.00814, "average": 0.973367, "min": 0.493011}, "location": {"width": 722, "top": 657, "height": 35, "left": 237}, "words": "心动过速、二联律、需要安装起搏器的完全性房室传导阻滞。在Ⅲ1期临床研究中"}, {"probability": {"variance": 0.012231, "average": 0.966869, "min": 0.477717}, "location": {"width": 827, "top": 697, "height": 58, "left": 235}, "words": "接受紫杉醇和顺铂联合化疗的非小细胞肺癌患者中,显著的心血管事件发生0 NG PHARMA"}, {"probability": {"variance": 0.016805, "average": 0.936863, "min": 0.559685}, "location": {"width": 847, "top": 740, "height": 42, "left": 238}, "words": "2%13%这种心血管事件的显著性增加可能是因为肺癌患者中心管危险因润广东"}, {"probability": {"variance": 0, "average": 0.999708, "min": 0.999539}, "location": {"width": 128, "top": 781, "height": 25, "left": 234}, "words": "素的增加所致"}, {"probability": {"variance": 0.012772, "average": 0.948248, "min": 0.695578}, "location": {"width": 192, "top": 783, "height": 36, "left": 861}, "words": "医药有限公司"}, {"probability": {"variance": 0.009829, "average": 0.970774, "min": 0.54484}, "location": {"width": 782, "top": 818, "height": 49, "left": 274}, "words": "在基线时患者就常有心电图异常。心电图异常通常不引起症状,也不剂量米1"}, {"probability": {"variance": 0.000143, "average": 0.995367, "min": 0.93338}, "location": {"width": 726, "top": 862, "height": 35, "left": 232}, "words": "限制性的,不需要干预。在所有患者中23%存在心电图异常。在研究入组前心电"}, {"probability": {"variance": 0.000174, "average": 0.995418, "min": 0.922148}, "location": {"width": 723, "top": 902, "height": 36, "left": 233}, "words": "图正常的患者中,14%的患者在治疗中会进展为异常心电记录。在心电监测中最"}, {"probability": {"variance": 0.001248, "average": 0.991418, "min": 0.790039}, "location": {"width": 723, "top": 942, "height": 38, "left": 232}, "words": "常见的是非特异性复极异常、窦性心动过缓、窦性心动过速、期前收缩基线心"}, {"probability": {"variance": 0.002283, "average": 0.988954, "min": 0.731608}, "location": {"width": 649, "top": 984, "height": 34, "left": 234}, "words": "电图正常的患者中,先前使用蒽环类治疗并不影响心电图异常的发生率"}, {"probability": {"variance": 0.011157, "average": 0.971284, "min": 0.429039}, "location": {"width": 711, "top": 1022, "height": 41, "left": 276}, "words": "心肌梗塞的发生偶有报道。充血性心力衰竭包括心功能障碍左室射血分数"}, {"probability": {"variance": 0.003459, "average": 0.986055, "min": 0.64596}, "location": {"width": 748, "top": 1066, "height": 33, "left": 230}, "words": "降低或心室功能衰竭的报道一般见于曾用过其他化疗(特别是蔥环类药物)的正"}, {"probability": {"variance": 3e-06, "average": 0.998021, "min": 0.994599}, "location": {"width": 195, "top": 1108, "height": 26, "left": 229}, "words": "用紫杉醇治疗的患者"}, {"probability": {"variance": 0, "average": 0.978936, "min": 0.978936}, "location": {"width": 28, "top": 1093, "height": 27, "left": 978}, "words": "心"}, {"probability": {"variance": 1.5e-05, "average": 0.998116, "min": 0.978987}, "location": {"width": 605, "top": 1150, "height": 28, "left": 274}, "words": "紫杉醇安全性的持续监测还包括偶有发生的房颤和室上性心动过速"}, {"probability": {"variance": 5e-06, "average": 0.99762, "min": 0.994707}, "location": {"width": 90, "top": 1191, "height": 26, "left": 271}, "words": "呼吸系统"}, {"probability": {"variance": 0.000107, "average": 0.995895, "min": 0.942561}, "location": {"width": 670, "top": 1231, "height": 33, "left": 274}, "words": "紫杉醇安全性的持续监测还包括偶有发生的间质性肺炎、肺纤维化、肺栓塞"}, {"probability": {"variance": 1e-06, "average": 0.999201, "min": 0.995281}, "location": {"width": 460, "top": 1272, "height": 29, "left": 232}, "words": "同时接受放射治疗的患者还偶有放射性肺炎的报道"}, {"probability": {"variance": 0.000141, "average": 0.995954, "min": 0.937835}, "location": {"width": 544, "top": 1313, "height": 32, "left": 273}, "words": "紫杉醇安全性的持续监测还偶有胸腔积液和呼吸衰竭的报告"}, {"probability": {"variance": 2e-06, "average": 0.998376, "min": 0.99669}, "location": {"width": 87, "top": 1355, "height": 25, "left": 271}, "words": "神经系统"}, {"probability": {"variance": 8e-05, "average": 0.996857, "min": 0.948431}, "location": {"width": 679, "top": 1395, "height": 33, "left": 273}, "words": "每一项研究报道的资料表明在这些研究中,神经毒性评价各不相同(见表"}, {"probability": {"variance": 4e-06, "average": 0.998675, "min": 0.992377}, "location": {"width": 723, "top": 1437, "height": 32, "left": 229}, "words": "28)。而且,神经系统临床症状的发生率和严重程度受到先前和或同时接受的"}, {"probability": {"variance": 0.000164, "average": 0.977329, "min": 0.964536}, "location": {"width": 18, "top": 1491, "height": 19, "left": 581}, "words": "15"}], "language": 3}